Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Aurora CO, Overland Park KS, Kansas City KS, Phoenix AZ,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Aurora CO, El Paso TX, Las Vegas NV, Boise ID,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase 3, Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Aurora CO, Salt Lake City UT, Omaha NE, Rochester MN,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: Aurora CO, Golden CO, Billings MT, Omaha NE,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Aurora CO, Las Vegas NV, Columbia MO, Tyler TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07566156
Phase 3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Aurora CO, Salt Lake City UT, Jupiter FL, Goodyear AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase 3, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Aurora CO, Santa Fe NM, Omaha NE, Waukee IA, Dallas TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Aurora CO, Grand Junction CO, Amarillo TX, Murray UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Aurora CO, Chandler AZ, Waukee IA, Henderson NV,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase 2, Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
for
Solid Tumors
Location: Wheat Ridge CO, Lincoln NE, Anderson TX, Spokane WA,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06953089
Phase 2, Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Thornton CO, Kansas City KS, Tyler TX, Reno NV,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
for
Chronic Pain, Intractable Pain, Low Back Pain,
Location: Greenwood CO, Corpus Christi TX, New Orleans LA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07190807
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
for
Pain
Location: Greenwood Village CO, Regina, Shreveport LA,